SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In
 
We’re going down soon, to move to a new Data Center today.  We’ll be up ASAP.  Sorry.

Soul Biotechnology Corp. – ‘10-Q’ for 3/31/23 – ‘EXCEL’

On:  Monday, 5/15/23, at 12:50pm ET   ·   For:  3/31/23   ·   Accession #:  1829126-23-3413   ·   File #:  0-56213

Previous ‘10-Q’:  ‘10-Q’ on 10/21/22 for 9/30/22   ·   Next:  ‘10-Q’ on 9/27/23 for 6/30/23   ·   Latest:  ‘10-Q’ on 11/20/23 for 9/30/23   ·   4 References:   

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 5/15/23  Soul Biotechnology Corp.          10-Q        3/31/23   38:2.2M                                   Empire Filings/FA

Quarterly Report   —   Form 10-Q

Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-Q        Quarterly Report                                    HTML    349K 
 2: EX-31.1     Certification -- §302 - SOA'02                      HTML     16K 
 3: EX-32.1     Certification -- §906 - SOA'02                      HTML     14K 
 9: R1          Cover                                               HTML     59K 
10: R2          Consolidated Balance Sheets (Unaudited)             HTML     95K 
11: R3          Consolidated Balance Sheets (Unaudited)             HTML     22K 
                (Parenthetical)                                                  
12: R4          Consolidated Statements of Operations (Unaudited)   HTML     98K 
13: R5          Consolidated Statements of Changes in               HTML     44K 
                Shareholders' Deficit (Unaudited)                                
14: R6          Consolidated Statements of Cash Flows (Unaudited)   HTML     61K 
15: R7          Organization and Description of the Business        HTML     32K 
16: R8          Summary of Significant Accounting Assumptions and   HTML     53K 
                Policies                                                         
17: R9          Going Concern                                       HTML     18K 
18: R10         Business Acquisition                                HTML     36K 
19: R11         Intangible Assets                                   HTML     17K 
20: R12         Related Party Transactions                          HTML     21K 
21: R13         Common Stock and Common Stock Payable               HTML     23K 
22: R14         Subsequent Events                                   HTML     16K 
23: R15         Summary of Significant Accounting Assumptions and   HTML     92K 
                Policies (Policies)                                              
24: R16         Business Acquisition (Tables)                       HTML     31K 
25: R17         Organization and Description of the Business        HTML     31K 
                (Details Narrative)                                              
26: R18         Summary of Significant Accounting Assumptions and   HTML     18K 
                Policies (Details Narrative)                                     
27: R19         Going Concern (Details Narrative)                   HTML     18K 
28: R20         Business Acquisition (Details)                      HTML     19K 
29: R21         Business Acquisition (Details 1)                    HTML     35K 
30: R22         Business Acquisition (Details Narrative)            HTML     28K 
31: R23         Intangible Assets (Details Narrative)               HTML     25K 
32: R24         Related Party Transactions (Details Narrative)      HTML     21K 
33: R25         Common Stock and Common Stock Payable (Details      HTML     42K 
                Narrative)                                                       
36: XML         IDEA XML File -- Filing Summary                      XML     61K 
34: XML         XBRL Instance -- soulbiotechno_10q_htm               XML    322K 
35: EXCEL       IDEA Workbook of Financial Reports                  XLSX     43K 
 5: EX-101.CAL  XBRL Calculations -- adob-20230331_cal               XML     80K 
 6: EX-101.DEF  XBRL Definitions -- adob-20230331_def                XML    141K 
 7: EX-101.LAB  XBRL Labels -- adob-20230331_lab                     XML    408K 
 8: EX-101.PRE  XBRL Presentations -- adob-20230331_pre              XML    321K 
 4: EX-101.SCH  XBRL Schema -- adob-20230331                         XSD     58K 
37: JSON        XBRL Instance as JSON Data -- MetaLinks              202±   266K 
38: ZIP         XBRL Zipped Folder -- 0001829126-23-003413-xbrl      Zip     78K 


‘EXCEL’   —   IDEA Workbook of Financial Reports


This is an IDEA Workbook.

        Download this Microsoft® Excel® .xlsx workbook


4 Previous Filings that this Filing References

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 2/10/22  Soul Biotechnology Corp.          8-K:1,2,3,5 2/10/22   14:1.2M                                   Empire Filings/FA
12/14/20  Soul Biotechnology Corp.          10-12G/A               5:709K                                   EdgarAgents LLC/FA
11/18/20  Soul Biotechnology Corp.          10-12G/A               6:838K                                   EdgarAgents LLC/FA
 1/19/18  Soul Biotechnology Corp.          S-1                    6:1M                                     S2 Filings LLC/FA
Top
Filing Submission 0001829126-23-003413   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Sat., May 11, 8:14:36.1am ET